Drug · DIN 02558130
NB-VALACYCLOVIR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 26, 2025; first marketed August 26, 2025.
- Drug Identification Number (DIN)
- 02558130
- Company (DIN owner)
- NB Pharma Inc.Québec, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Valaciclovir J05AB11
- Class
- Human
- Record last updated
- November 5, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) | 500 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 3, 2025: NOC 35465Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
Other DINs named NB-VALACYCLOVIR
- DIN 02558149 · Approved